Evaluation of the predictive validity of the ASAS axial spondyloarthritis criteria in the DESIR cohort (2019)
https://pubmed.ncbi.nlm.nih.gov/30873948/

Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatment (2018)
https://pubmed.ncbi.nlm.nih.gov/30183594/

An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS (2018)
https://pubmed.ncbi.nlm.nih.gov/29038299/